Short verdict: Keep, but phrase as insulation/contact-domain architecture rather than absolute fences. TAD boundaries can constrain enhancer action, yet expression effects after boundary loss are locus-specific.
What the current graph claims
Node definition: TAD boundaries and insulation, especially convergent CTCF/cohesin loop-extrusion barriers that reduce inappropriate enhancer-promoter communication.
Incoming edges:
ZONES -> FENCES: constrains [context/dashed]
Outgoing edges:
FENCES -> BRIDGES: delimits
Literature-grounded assessment
What is strongly supported: Cohesin extrusion stopped or slowed by oriented CTCF sites explains many loops and contact domains; boundary perturbations can cause enhancer adoption and disease phenotypes.
What is context-dependent: TAD strength varies by cell type, cohesin residence, transcription, and chromatin state. Some genes tolerate boundary deletion with limited expression change.
What is weak, controversial, or assay-biased: The node label risks overpromising hard insulation. Assays differ: population Hi-C domains, single-cell structures, and functional enhancer boundaries are related but not identical.
What may be duplicate biology under another name: Partial overlap with BRIDGES because loops can be both structural and regulatory.
Missing or excessive graph structure
Missing edges: Add caveat from SHUFFLER/OPENER/KEYS or transcription to boundary permeability where chromatin state changes contact use.
Excess edges: FENCES -> BRIDGES should be “biases/limits” rather than universally delimits.
Candidate splits: No split, unless separating CTCF/cohesin loops from broader TAD/domain compartments.
Candidate merges: No merge.
Candidate renames: INSULATORS or DOMAINS would be more literal than FENCES.
Recommendation
Concrete graph change, if any: Keep with wording that boundaries are probabilistic insulators produced largely by cohesin/CTCF loop extrusion.
Concrete technical-notes/blog wording change, if any: Mirror the graph recommendation in the glossary and relation catalogue, and explicitly mark the confidence/caveat where the claim is context-dependent or assay-sensitive.